T1	CHEM 8 20	epoprostenol
#1	AnnotatorNotes T1	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T2	CHEM 42 50	heparina
#2	AnnotatorNotes T2	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T3	ANAT 145 150	renal
#3	AnnotatorNotes T3	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T4	CHEM 216 230	anticoagulante
#4	AnnotatorNotes T4	C0003280; Anticoagulants; Pharmacologic Substance
T5	PROC 273 295	depuración extrarrenal
T6	CHEM 350 362	epoprostenol
#5	AnnotatorNotes T6	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T7	DISO 407 415	sangrado
#6	AnnotatorNotes T7	C0019080; Hemorrhage; Pathologic Function
T8	CHEM 430 453	heparina no fraccionada
#7	AnnotatorNotes T8	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T9	CHEM 455 458	HnF
#8	AnnotatorNotes T9	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T10	PROC 1114 1134	recuento plaquetario
T11	DISO 477 501	problemas de coagulación
#9	AnnotatorNotes T11	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T12	PROC 534 565	Estudio prospectivo de cohortes
#10	AnnotatorNotes T12	C1709709; Prospective Cohort Study; Research Activity
T13	PROC 739 753	Intervenciones
#11	AnnotatorNotes T13	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T14	PROC 758 773	anticoagulación
#12	AnnotatorNotes T14	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T15	PROC 791 800	perfusión
#13	AnnotatorNotes T15	C0031001; Perfusion (procedure); Therapeutic or Preventive Procedure
T16	CHEM 846 849	HnF
#14	AnnotatorNotes T16	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T17	CHEM 874 886	epoprostenol
#15	AnnotatorNotes T17	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T18	CHEM 935 947	epoprostenol
#16	AnnotatorNotes T18	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T19	CHEM 950 953	HnF
#17	AnnotatorNotes T19	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T20	DISO 1097 1109	coagulopatía
#18	AnnotatorNotes T20	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T21	ANAT 1123 1134	plaquetario
#19	AnnotatorNotes T21	C0005821; Blood Platelets; Cell
T22	DISO 1152 1160	sangrado
#20	AnnotatorNotes T22	C0019080; Hemorrhage; Pathologic Function
T23	CHEM 1165 1179	anticoagulante
#21	AnnotatorNotes T23	C0003280; Anticoagulants; Pharmacologic Substance
T24	DISO 1312 1319	coágulo
#22	AnnotatorNotes T24	C0302148; Blood Clot; Pathologic Function
T25	CHEM 1328 1331	HnF
#23	AnnotatorNotes T25	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T26	CHEM 1418 1430	epoprostenol
#24	AnnotatorNotes T26	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T27	PROC 1487 1504	terapia combinada
#25	AnnotatorNotes T27	C0013218; Combination Drug Therapy; Therapeutic or Preventive Procedure
T28	CHEM 1575 1587	epoprostenol
#26	AnnotatorNotes T28	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T29	CHEM 1739 1742	HnF
#27	AnnotatorNotes T29	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T30	PROC 1818 1835	terapia combinada
#28	AnnotatorNotes T30	C0013218; Combination Drug Therapy; Therapeutic or Preventive Procedure
T31	DISO 1864 1876	coagulopatía
#29	AnnotatorNotes T31	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T32	DISO 1879 1890	trombopenia
#30	AnnotatorNotes T32	C0040034; Thrombocytopenia; Disease or Syndrome
T33	CHEM 1922 1925	HnF
#31	AnnotatorNotes T33	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T34	DISO 1940 1948	sangrado
#32	AnnotatorNotes T34	C0019080; Hemorrhage; Pathologic Function
T35	CHEM 2018 2030	epoprostenol
#33	AnnotatorNotes T35	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T36	DISO 2047 2055	sangrado
#34	AnnotatorNotes T36	C0019080; Hemorrhage; Pathologic Function
T37	DISO 2113 2121	sangrado
#35	AnnotatorNotes T37	C0019080; Hemorrhage; Pathologic Function
T38	CHEM 2125 2137	epoprostenol
#36	AnnotatorNotes T38	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T39	CHEM 2208 2211	HnF
#37	AnnotatorNotes T39	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T40	DISO 2238 2246	sangrado
#38	AnnotatorNotes T40	C0019080; Hemorrhage; Pathologic Function
T41	CHEM 2310 2322	epoprostenol
#39	AnnotatorNotes T41	C0033567; epoprostenol; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T42	CHEM 2327 2330	HnF
#40	AnnotatorNotes T42	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T43	PROC 208 230	régimen anticoagulante
#41	AnnotatorNotes T43	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T44	PROC 1617 1633	tensión arterial
#42	AnnotatorNotes T44	C0005824; Blood pressure determination; Health Care Activity
T45	ANAT 1625 1633	arterial
#43	AnnotatorNotes T45	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T46	PROC 1909 1917	tratados
#44	AnnotatorNotes T46	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T47	DISO 2265 2276	coagulación
#45	AnnotatorNotes T47	C0302148; Blood Clot; Pathologic Function
T48	PROC 113 150	técnicas continuas de reemplazo renal
#46	AnnotatorNotes T48	C3649547; Continuous Renal Replacement Therapy; Therapeutic or Preventive Procedure
T49	Date 162 173	Actualmente
T51	LIVB 383 392	pacientes
#47	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Spec_cue 397 406	riesgo de
T54	LIVB 463 472	pacientes
#48	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 557 565	cohortes
#49	AnnotatorNotes T55	C0599755; Cohort; Population Group
T56	Date 631 635	1994
T58	Dose 824 832	5-7 U/kg
T59	Dose 956 964	2,5 U/kg
T60	Neg_cue 1059 1071	retirada del
T61	LIVB 1229 1238	pacientes
#50	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Duration 1264 1276	66.957 horas
T63	Duration 1380 1388	39 horas
T64	Duration 1448 1456	32 horas
T65	Duration 1522 1530	27 horas
T67	Duration 1774 1782	14 horas
T68	Duration 1806 1814	27 horas
T69	Neg_cue 1852 1863	ausencia de
T70	LIVB 2089 2098	pacientes
#51	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	Spec_cue 2103 2112	riesgo de
T72	Spec_cue 2228 2237	riesgo de
T73	LIVB 2251 2260	pacientes
#52	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T75	Dose 2334 2345	dosis bajas
#53	AnnotatorNotes T75	C0445550; Low dose; Quantitative Concept
T76	PHYS 490 501	coagulación
#54	AnnotatorNotes T76	C0005778; Blood coagulation; Organ or Tissue Function
T50	DEVI 516 523	filtros
#55	AnnotatorNotes T50	C1875155; Filter; Medical device
T53	DEVI 582 589	filtros
#56	AnnotatorNotes T53	C1875155; Filter; Medical device
T57	Frequency 964 970	/ hora
T77	Frequency 832 837	/hora
T78	Dose 855 864	4-5 ng/kg
T79	Frequency 864 868	/min
T80	DEVI 1072 1078	filtro
#57	AnnotatorNotes T80	C1875155; Filter; Medical device
T81	DEVI 1255 1262	filtros
#58	AnnotatorNotes T81	C1875155; Filter; Medical device
T82	DEVI 1349 1356	filtros
#59	AnnotatorNotes T82	C1875155; Filter; Medical device
T66	DEVI 1699 1706	filtros
#60	AnnotatorNotes T66	C1875155; Filter; Medical device
T74	DEVI 2291 2298	filtros
#61	AnnotatorNotes T74	C1875155; Filter; Medical device
T83	Duration 1410 1415	19-75
T84	Duration 1552 1557	19-41
T85	Duration 1478 1483	17-48
T86	PROC 1675 1693	disminuir la dosis
#62	AnnotatorNotes T86	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
A1	Assertion T7 Speculated
A2	Assertion T80 Negated
A3	Assertion T31 Negated
A4	Assertion T32 Negated
A5	Assertion T37 Speculated
A6	Assertion T40 Speculated
T87	Neg_cue 174 176	no
T88	CONC 184 192	consenso
R1	Negation Arg1:T87 Arg2:T88	
A7	Assertion T88 Negated
R2	Overlap Arg1:T88 Arg2:T49	
T89	Quantifier_or_Qualifier 442 453	fraccionada
A8	Assertion T89 Negated
T90	Neg_cue 439 441	no
R3	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T89	
R4	Negation Arg1:T90 Arg2:T89	
T91	Quantifier_or_Qualifier 21 28	aislado
#63	AnnotatorNotes T91	C0205171; Singular; Quantitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T91	
R6	Combined_with Arg1:T1 Arg2:T2	
R7	Location_of Arg1:T3 Arg2:T48	
R8	Used_for Arg1:T4 Arg2:T43	
R9	Overlap Arg1:T43 Arg2:T5	
T92	Quantifier_or_Qualifier 363 379	de forma aislada
#64	AnnotatorNotes T92	C0205171; Singular; Quantitative Concept
R12	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T92	
R13	Experiences Arg1:T51 Arg2:T6	
R14	Experiences Arg1:T51 Arg2:T7	
R15	Speculation Arg1:T52 Arg2:T7	
R16	Combined_with Arg1:T6 Arg2:T8	
R17	Combined_with Arg1:T6 Arg2:T9	
T93	Quantifier_or_Qualifier 502 508	precoz
#65	AnnotatorNotes T93	C1279930; Precocious; Temporal Concept
R18	Has_Quantifier_or_Qualifier Arg1:T76 Arg2:T93	
R19	Experiences Arg1:T54 Arg2:T11	
R20	Experiences Arg1:T54 Arg2:T76	
R21	Experiences Arg1:T54 Arg2:T8	
R22	Experiences Arg1:T54 Arg2:T9	
R23	Experiences Arg1:T54 Arg2:T7	
R24	Experiences Arg1:T54 Arg2:T6	
R25	Experiences Arg1:T51 Arg2:T11	
R26	Experiences Arg1:T51 Arg2:T76	
R27	After Arg1:T12 Arg2:T56	
T94	Quantifier_or_Qualifier 801 810	prefiltro
R28	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T94	
R30	Used_for Arg1:T16 Arg2:T14	
R31	Has_Frequency Arg1:T16 Arg2:T77	
R32	Has_Dose_or_Strength Arg1:T16 Arg2:T58	
R33	Has_Frequency Arg1:T17 Arg2:T79	
R34	Has_Dose_or_Strength Arg1:T17 Arg2:T78	
R35	Used_for Arg1:T17 Arg2:T14	
R36	Combined_with Arg1:T18 Arg2:T19	
R37	Has_Dose_or_Strength Arg1:T19 Arg2:T59	
R38	Has_Frequency Arg1:T19 Arg2:T57	
R39	Has_Dose_or_Strength Arg1:T18 Arg2:T59	
R40	Has_Frequency Arg1:T18 Arg2:T57	
R41	Negation Arg1:T60 Arg2:T80	
#66	AnnotatorNotes T10	C0032181; Platelet Count measurement; Laboratory Procedure
R42	Before Arg1:T80 Arg2:T22	
T95	CONC 1021 1044	duración de cada filtro
R43	Has_Duration_or_Interval Arg1:T81 Arg2:T62	
R44	Experiences Arg1:T61 Arg2:T24	
R46	Has_Duration_or_Interval Arg1:T25 Arg2:T63	
R47	Has_Duration_or_Interval Arg1:T25 Arg2:T83	
R48	Has_Duration_or_Interval Arg1:T26 Arg2:T64	
R49	Has_Duration_or_Interval Arg1:T26 Arg2:T85	
R50	Has_Duration_or_Interval Arg1:T27 Arg2:T65	
R51	Has_Duration_or_Interval Arg1:T27 Arg2:T84	
R59	Location_of Arg1:T45 Arg2:T44	
T96	Observation 1602 1633	descenso de la tensión arterial
#67	AnnotatorNotes T96	C0020649; Hypotension; Finding
R60	Before Arg1:T28 Arg2:T96	
T97	DEVI 1646 1653	filtros
#68	AnnotatorNotes T97	C1875155; Filter; Medical device
R62	Used_for Arg1:T28 Arg2:T86	
T98	Quantifier_or_Qualifier 1707 1721	anticoagulados
R63	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T98	
T99	CONC 1757 1770	supervivencia
#69	AnnotatorNotes T99	C0038955; survivorship; Temporal Concept
R65	Has_Duration_or_Interval Arg1:T99 Arg2:T67	
R66	Has_Duration_or_Interval Arg1:T99 Arg2:T68	
R68	Negation Arg1:T69 Arg2:T31	
R69	Negation Arg1:T69 Arg2:T32	
T100	DEVI 1901 1908	filtros
#70	AnnotatorNotes T100	C1875155; Filter; Medical device
R70	Used_for Arg1:T33 Arg2:T46	
T101	Quantifier_or_Qualifier 1949 1953	leve
R71	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T101	
R73	Before Arg1:T100 Arg2:T34	
T102	Quantifier_or_Qualifier 1964 1972	moderado
R74	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T102	
T103	Quantifier_or_Qualifier 1984 1989	grave
#71	AnnotatorNotes T103	C1547227; Severe - Severity of Illness Code; Intellectual Product
R75	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T103	
T104	DEVI 2006 2013	filtros
#72	AnnotatorNotes T104	C1875155; Filter; Medical device
R76	Combined_with Arg1:T104 Arg2:T35	
R77	Before Arg1:T104 Arg2:T36	
T105	Quantifier_or_Qualifier 2056 2060	leve
R78	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T105	
R79	Experiences Arg1:T70 Arg2:T37	
R80	Experiences Arg1:T70 Arg2:T38	
R81	Speculation Arg1:T71 Arg2:T37	
T106	Quantifier_or_Qualifier 2138 2154	de forma aislada
#73	AnnotatorNotes T106	C0205171; Singular; Quantitative Concept
R82	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T106	
T107	DEVI 2195 2202	filtros
#74	AnnotatorNotes T107	C1875155; Filter; Medical device
R83	Combined_with Arg1:T107 Arg2:T39	
R85	Speculation Arg1:T72 Arg2:T40	
R86	Before Arg1:T107 Arg2:T40	
R87	Before Arg1:T107 Arg2:T37	
R88	Experiences Arg1:T70 Arg2:T39	
R89	Experiences Arg1:T70 Arg2:T40	
R90	Experiences Arg1:T73 Arg2:T47	
R91	Experiences Arg1:T73 Arg2:T41	
R92	Combined_with Arg1:T41 Arg2:T42	
R93	Has_Dose_or_Strength Arg1:T42 Arg2:T75	
T108	Quantifier_or_Qualifier 2277 2283	precoz
#75	AnnotatorNotes T108	C1279930; Precocious; Temporal Concept
R94	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T108	
R95	Location_of Arg1:T45 Arg2:T96	
R96	Causes Arg1:T29 Arg2:T99	
R98	Combined_with Arg1:T74 Arg2:T41	
T109	CONC 1191 1196	dosis
#76	AnnotatorNotes T109	C0178602; Dosage; Quantitative Concept
R10	Overlap Arg1:T14 Arg2:T15	
R11	Used_for Arg1:T109 Arg2:T23	
T110	Observation 1617 1633;1659 1671	tensión arterial se normalizó
#77	AnnotatorNotes T110	C4068890; Normal tension; Finding
R29	Causes Arg1:T86 Arg2:T110	
R45	Combined_with Arg1:T100 Arg2:T33	
#78	AnnotatorNotes T101	C2945599; Mild (qualifier value); Qualitative Concept
#79	AnnotatorNotes T102	C0205081; Moderate (severity modifier); Qualitative Concept
#80	AnnotatorNotes T105	C2945599; Mild (qualifier value); Qualitative Concept
R52	Combined_with Arg1:T38 Arg2:T107	
#81	AnnotatorNotes T5	C0206074; Renal Replacement Therapy; Therapeutic or Preventive Procedure (?)
#82	AnnotatorNotes T49	C0521116; Current (present time); Temporal Concept
A9	Experiencer T51 Patient
A10	Experiencer T54 Patient
A11	Experiencer T55 Patient
A12	Experiencer T70 Patient
A13	Experiencer T73 Patient
A14	Experiencer T61 Patient
R53	Has_Result_or_Value Arg1:T44 Arg2:T96	
